Monoamine oxidase inhibition by the MAO-A inhibitors brofaromine and clorgyline in healthy volunteers
- 1 October 1994
- journal article
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 95 (3) , 241-245
- https://doi.org/10.1007/bf01271570
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Efficacy of moclobemide in different patient groups: a meta-analysis of studiesPsychopharmacology, 1992
- Brofaromine - a Selective, Reversible, and Short-Acting MAO-A Inhibitor: Review of the Pharmacological and Clinical FindingsPharmacopsychiatry, 1991
- Monoamine oxidase inhibition by phenelzine and brofaromine in healthy volunteersClinical Pharmacology & Therapeutics, 1989
- ORAL TYRAMINE PRESSOR TEST AND THE SAFETY OF MONOAMINE-OXIDASE INHIBITOR DRUGS - COMPARISON OF BROFAROMINE AND TRANYLCYPROMINE IN HEALTHY-SUBJECTS1988
- Oral Tyramine Pressor Test and the Safety of Monoamine Oxidase Inhibitor DrugsJournal of Clinical Psychopharmacology, 1988
- Dissociation of norepinephrine turnover from alpha-2 responses after clorgilineClinical Pharmacology & Therapeutics, 1988
- Tryptamine Kinetics in Human VolunteersPublished by Springer Nature ,1985
- An improved procedure of 3-methoxy-4-hydroxyphenyl-ethylene glycol determination by gas-liquid chromatographyAnalytical Biochemistry, 1970